Additional file 1 of Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

Name: Additional file 1 of Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry
Creator: Iñiguez, Luis P.; Marston, Jez L.; Powell, Timothy R.; Han, Yuling; Copertino, Dennis C.; Chen, Shuibing; Nixon, Douglas F.; Schwartz, Robert E.; Duarte, Rodrigo R. R.; Bram, Yaron
Published: 2021-09-10T00:00:00+08:00

Figshare2021-10-05 更新2026-04-08 收录

药物再利用筛选

抗病毒药物发现

数据链接：

https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Identifying_FDA-approved_drugs_with_multimodal_properties_against_COVID-19_using_a_data-driven_approach_and_a_lung_organoid_model_of_SARS-CoV-2_entry/16599575/1 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 1: Table S1. Genes differentially expressed in lung cancer cells after exposure to SARS-CoV-2. Source: Blanco-Melo et al. (2020). Table S2. Connectivity mapping results generated by querying the SARS-CoV-2 transcriptional signature into CMap. Table S3. Source of the drug structures utilized in the chemoinformatic analysis testing for interaction with SARS-CoV-2 enzymes.

提供机构：

Iñiguez, Luis P.; Marston, Jez L.; Powell, Timothy R.; Han, Yuling; Copertino, Dennis C.; Chen, Shuibing; Nixon, Douglas F.; Schwartz, Robert E.; Duarte, Rodrigo R. R.; Bram, Yaron

创建时间：

2021-09-10